ARRB2 (β-arrestin 2) expression has been shown to modulate the growth of colorectal cancer [48], glioblastoma [49], lung cancer [50], ovarian cancer [51], and prostate cancer [52]. This evidence concerns the gene ARRB2 and prostate cancer.